Welcome


The Pennsylvania Society of Oncology and Hematology represents more than 200 physicians and other health care professionals who care for cancer patients. The Society is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.

Membership in the Society is open to physicians, allied health professionals, and institutions with a demonstrated interest and involvement in the care of patients with hematologic and oncologic disorders. It is also open to residents and fellows who are actively enrolled in a full-time residency program in hematology or oncology in Pennsylvania or who are in an appropriate fellowship program. Corporate entities involved in the care and treatment of cancer patients may also become members.

The site provides resources for cancer patients, including a searchable database of Society members for those individuals seeking an oncologist, hematologist, surgical oncologist, or radiation oncologist.

The Pennsylvania Society of Oncology and Hematology is grateful to our Corporate Sponsors, whose donations help us fulfill our mission.


Tenacious approach helps this physician get policymakers on board

The AMA Wire® “Members Move Medicine” series profiles a wide variety of doctors, offering a glimpse into the passions of women and men navigating new courses in American medicine.

On the move with: Marilyn J. Heine, MD, a physician in emergency medicine and hematology-oncology in active clinical practice in southeast Pennsylvania.

Continue Reading


 


The Conquer Cancer Foundation (CCF) has established a Hurricane Relief Fund dedicated to people with cancer who have been devastated by hurricanes and are in need of critical support services. For additional information and to donate, click here: www.conquer.org/relieffund

ASSESS. CHANGE. TEST.

CAP, ACCC, LUNGevity & CHEST partner on Process Improvement Toolkit for molecular testing programs for Non-Small Cell Lung Cancer (NSCLC).

Read more  (1.17MB pdf)

Approval of BAVENICO® Injection

EMD Serono and Pfizer announced the approval of BAVENCIO® (avelumab) Injection on March 23, 2017.

Learn More:
Approval Information (pdf)
Full Prescribing Information (pdf)                     

Questions regarding this approval should be directed to: Susan Sproat, CPA, CHONC, CMR
at Pfizer Oncology (
susan.r.sproat@pfizer.com).\

 
 

Our Corporate Members

Pennsylvania Society of Oncology and Hematology
777 East Park Drive, PO Box 8820
Harrisburg, PA 17105-8820
(717) 558-7750 phone
(717) 558-7841 fax

This website brought to you by:

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Our Corporate Members